Armune BioScience closed on a newly expanded Series A worth $4 million last week, and the life sciences firm has its target set on a $25M Series B round for later this year.
News from Concentrate
Subscribe to our newsletters
Don’t miss an event, announcement, or job opportunity. Get news delivered to your inbox and stay informed about what is going on in tech, business, and talent in the greater Ann Arbor region.